People With Advanced AIDS Benefit From Dolutegravir Treatment

(MedPage Today) -- MONTREAL--Patients with advanced HIV/AIDS infections had higher proportion of viral suppression with dolutegravir (Tivicay) treatment versus efavirenz (Sustiva) treatment, a researcher reported.
At 48 weeks, 73.9% of the...